Lv0
0 积分 2024-10-24 加入
Cardiovascular Outcomes with Tirzepatide versus Dulaglutide in Type 2 Diabetes
5天前
已完结
Cardiovascular Outcomes with Tirzepatide versus Dulaglutide in Type 2 Diabetes
5天前
已完结
Semaglutide and walking capacity in people with symptomatic peripheral artery disease and type 2 diabetes (STRIDE): a phase 3b, double-blind, randomised, placebo-controlled trial
20天前
已关闭
Targeting the RANKL/RANK/OPG Axis for Cancer Therapy
20天前
已完结
Weight regain after cessation of medication for weight management: systematic review and meta-analysis
25天前
已完结
Resmetirom (MGL-3196) for the treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
3个月前
已完结
Safety and efficacy of once-weekly efruxifermin versus placebo in metabolic dysfunction-associated steatohepatitis (HARMONY): 96-week results from a multicentre, randomised, double-blind, placebo-controlled, phase 2b trial
4个月前
已完结
Oral Semaglutide at a Dose of 25 mg in Adults with Overweight or Obesity
4个月前
已完结
Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes
6个月前
已完结
Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes
6个月前
已完结
皖公网安备34019202002308
